Stock Track | PegBio Soars 6.86% Intraday on GLP-1 Drug Commercialization Deals

Stock Track

May 20

PegBio Co-B's stock was soaring 6.86% during intraday trading on Wednesday, extending a recent rally for the biopharmaceutical company.

The sustained upward momentum is driven by the company's strategic commercialization partnership with Tengrui Pharmaceutical for Paidakang (PB-119), a long-acting GLP-1 receptor agonist. Under the agreement, Tengrui Pharmaceutical secured exclusive mainland China commercialization rights, committing approximately HK$140 million in upfront payments and targeting cumulative sales exceeding RMB 10 billion.

Further catalyzing investor enthusiasm is a separate strategic cooperation signed to launch Paidakang on a major internet hospital platform for its nationwide online debut, significantly expanding the drug's potential market access.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1161154336"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1161154336\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1161154336?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-20 09:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1161154336","market":"hk","top_or_hot":-1,"title":"Stock Track | PegBio Soars 6.86% Intraday on GLP-1 Drug Commercialization Deals","media":"Stock Track","content":"<p>PegBio Co-B's stock was soaring 6.86% during intraday trading on Wednesday, extending a recent rally for the biopharmaceutical company.</p><p>The sustained upward momentum is driven by the company's strategic commercialization partnership with Tengrui Pharmaceutical for Paidakang (PB-119), a long-acting GLP-1 receptor agonist. Under the agreement, Tengrui Pharmaceutical secured exclusive mainland China commercialization rights, committing approximately HK$140 million in upfront payments and targeting cumulative sales exceeding RMB 10 billion.</p><p>Further catalyzing investor enthusiasm is a separate strategic cooperation signed to launch Paidakang on a major internet hospital platform for its nationwide online debut, significantly expanding the drug's potential market access.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | PegBio Soars 6.86% Intraday on GLP-1 Drug Commercialization Deals</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | PegBio Soars 6.86% Intraday on GLP-1 Drug Commercialization Deals\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-20 09:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>PegBio Co-B's stock was soaring 6.86% during intraday trading on Wednesday, extending a recent rally for the biopharmaceutical company.</p><p>The sustained upward momentum is driven by the company's strategic commercialization partnership with Tengrui Pharmaceutical for Paidakang (PB-119), a long-acting GLP-1 receptor agonist. Under the agreement, Tengrui Pharmaceutical secured exclusive mainland China commercialization rights, committing approximately HK$140 million in upfront payments and targeting cumulative sales exceeding RMB 10 billion.</p><p>Further catalyzing investor enthusiasm is a separate strategic cooperation signed to launch Paidakang on a major internet hospital platform for its nationwide online debut, significantly expanding the drug's potential market access.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02565","symbol_name":"派格生物医药-B","start_time":0,"source_url":"","article_id":"1161154336","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1161154336","pubTimestamp":1779242132,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"PegBio Co-B's stock was soaring 6.86% during intraday trading on Wednesday, extending a recent rally for the biopharmaceutical company.The sustained upward momentum is driven by the company's...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02565":"派格生物医药-B"},"translate_title":"个股追踪|派格生物盘中大涨6.86%因GLP-1药物商业化交易","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02565":1},"content_text":"PegBio Co-B's stock was soaring 6.86% during intraday trading on Wednesday, extending a recent rally for the biopharmaceutical company.The sustained upward momentum is driven by the company's strategic commercialization partnership with Tengrui Pharmaceutical for Paidakang (PB-119), a long-acting GLP-1 receptor agonist. Under the agreement, Tengrui Pharmaceutical secured exclusive mainland China commercialization rights, committing approximately HK$140 million in upfront payments and targeting cumulative sales exceeding RMB 10 billion.Further catalyzing investor enthusiasm is a separate strategic cooperation signed to launch Paidakang on a major internet hospital platform for its nationwide online debut, significantly expanding the drug's potential market access.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}